Study name |
Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID‐19) |
Starting date |
10 February 2020 |
Contact information |
Chunli Liu The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China +86 13560158649 | chunli@gird.cn |
Methods |
Prospective cohort, non‐randomised, open‐label, 2 parallel and comparative arms |
Participants |
120 participants, 18‐80 years, female and male Inclusion criteria
Patients diagnosed with new coronavirus pneumonia and in need of hospitalisation: they meet the diagnostic criteria of the diagnosis and treatment programme for new coronavirus pneumonia (trial 5th edition) issued by the National Health Commission
Pneumonia with novel coronavirus confirmed by aetiological nucleic acid test
Aged 18‐80 years
Signed informed consent
VTE score was ≥ 4, and there were no higher blood risk factors
Exclusion criteria
Pregnant women or lactating women
Severe liver function damage (Child‐Pugh grade C)
Severe renal impairment (CrCl ≤ 15mL/min)
Have any co‐existing medical conditions or diseases that the investigator determines may impair the conduct of the study
Social and mental disability, no legal capacity/restricted capacity
Refuse to sign the informed consent
VTE score < 4
Higher blood risk factors
|
Interventions |
Experimental: 7/5000 LMWH therapy Comparison: mechanical prevention |
Outcomes |
Primary: biochemical indicators Secondary: not described |
Notes |
ChiCTR2000030946 | No data provided |